10 Einträge von 79 mit cidp cell
www.cslbehring.ch
Datum der Indexierung 08.01.2024 08:19:49
erkannte Namen Grant Provider |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords studies plasma | behring nouvelles | with savoir | that notre | disease plus | nous research | application including | products quality | investigator patients | initiated clinical |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
CIDP) including wear-off, dose titration, dose conversion from intravenous immunoglobulins (IVIg) to subcutaneous immunoglobulins (SCIg), loading dose and dosing by body mass index (BMI) or fat percent versus weight, quality-of-life in CIDP patients, cell and organ transplantation. Specific Research Priorities include: Graft versus Host Disease (GvHD) following: Hematopoietic Cell Transplant (HCT) Burden of disease, natural course of disease, and understanding the role of cond
Text Inhalt Text aus URL
Log Metriken 1036321
erkannte Namen Grant Provider |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords studies plasma | behring nouvelles | with savoir | that notre | disease plus | nous research | application including | products quality | investigator patients | initiated clinical |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
CIDP) including wear-off, dose titration, dose conversion from intravenous immunoglobulins (IVIg) to subcutaneous immunoglobulins (SCIg), loading dose and dosing by body mass index (BMI) or fat percent versus weight, quality-of-life in CIDP patients, cell and organ transplantation. Specific Research Priorities include: Graft versus Host Disease (GvHD) following: Hematopoietic Cell Transplant (HCT) Burden of disease, natural course of disease, and understanding the role of cond
Text Inhalt Text aus URL
Log Metriken 1036321
www.cslbehring.ch
Datum der Indexierung 21.01.2024 21:23:06
erkannte Namen Grant Provider |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords studies through | behring investigator-initiated | with nouvelles | that plus | disease notre | nous research | initiated including | patients quality | clinical products | application investigator |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
CIDP) including wear-off, dose titration, dose conversion from intravenous immunoglobulins (IVIg) to subcutaneous immunoglobulins (SCIg), loading dose and dosing by body mass index (BMI) or fat percent versus weight, quality-of-life in CIDP patients, cell and organ transplantation. Specific Research Priorities include: Graft versus Host Disease (GvHD) following: Hematopoietic Cell Transplant (HCT) Burden of disease, natural course of disease, and understanding the role of cond
Text Inhalt Text aus URL
Log Metriken 1036321
erkannte Namen Grant Provider |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords studies through | behring investigator-initiated | with nouvelles | that plus | disease notre | nous research | initiated including | patients quality | clinical products | application investigator |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
CIDP) including wear-off, dose titration, dose conversion from intravenous immunoglobulins (IVIg) to subcutaneous immunoglobulins (SCIg), loading dose and dosing by body mass index (BMI) or fat percent versus weight, quality-of-life in CIDP patients, cell and organ transplantation. Specific Research Priorities include: Graft versus Host Disease (GvHD) following: Hematopoietic Cell Transplant (HCT) Burden of disease, natural course of disease, and understanding the role of cond
Text Inhalt Text aus URL
Log Metriken 1036321
www.cslbehring.ch
Datum der Indexierung 15.01.2024 02:32:16
erkannte Namen Grant Provider |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords studies through | behring investigator-initiated | with nouvelles | that plus | disease notre | nous research | initiated including | patients quality | clinical products | application investigator |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
CIDP) including wear-off, dose titration, dose conversion from intravenous immunoglobulins (IVIg) to subcutaneous immunoglobulins (SCIg), loading dose and dosing by body mass index (BMI) or fat percent versus weight, quality-of-life in CIDP patients, cell and organ transplantation. Specific Research Priorities include: Graft versus Host Disease (GvHD) following: Hematopoietic Cell Transplant (HCT) Burden of disease, natural course of disease, and understanding the role of cond
Text Inhalt Text aus URL
Log Metriken 1036321
erkannte Namen Grant Provider |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords studies through | behring investigator-initiated | with nouvelles | that plus | disease notre | nous research | initiated including | patients quality | clinical products | application investigator |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
CIDP) including wear-off, dose titration, dose conversion from intravenous immunoglobulins (IVIg) to subcutaneous immunoglobulins (SCIg), loading dose and dosing by body mass index (BMI) or fat percent versus weight, quality-of-life in CIDP patients, cell and organ transplantation. Specific Research Priorities include: Graft versus Host Disease (GvHD) following: Hematopoietic Cell Transplant (HCT) Burden of disease, natural course of disease, and understanding the role of cond
Text Inhalt Text aus URL
Log Metriken 1036321
www.cslbehring.ch
Datum der Indexierung 10.01.2024 05:07:55
erkannte Namen Grant Provider |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords studies through | behring investigator-initiated | with nouvelles | that plus | disease notre | nous research | initiated including | patients quality | clinical products | application investigator |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
CIDP) including wear-off, dose titration, dose conversion from intravenous immunoglobulins (IVIg) to subcutaneous immunoglobulins (SCIg), loading dose and dosing by body mass index (BMI) or fat percent versus weight, quality-of-life in CIDP patients, cell and organ transplantation. Specific Research Priorities include: Graft versus Host Disease (GvHD) following: Hematopoietic Cell Transplant (HCT) Burden of disease, natural course of disease, and understanding the role of cond
Text Inhalt Text aus URL
Log Metriken 1036321
erkannte Namen Grant Provider |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords studies through | behring investigator-initiated | with nouvelles | that plus | disease notre | nous research | initiated including | patients quality | clinical products | application investigator |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
CIDP) including wear-off, dose titration, dose conversion from intravenous immunoglobulins (IVIg) to subcutaneous immunoglobulins (SCIg), loading dose and dosing by body mass index (BMI) or fat percent versus weight, quality-of-life in CIDP patients, cell and organ transplantation. Specific Research Priorities include: Graft versus Host Disease (GvHD) following: Hematopoietic Cell Transplant (HCT) Burden of disease, natural course of disease, and understanding the role of cond
Text Inhalt Text aus URL
Log Metriken 1036321
www.cslbehring.ch
Datum der Indexierung 08.01.2024 08:22:21
erkannte Namen Grant Provider |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords behring areas | with including | studies diseases | that health | disease learn | products research | clinical your | more patients | application quality | initiated investigator |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
CIDP) including wear-off, dose titration, dose conversion from intravenous immunoglobulins (IVIg) to subcutaneous immunoglobulins (SCIg), loading dose and dosing by body mass index (BMI) or fat percent versus weight, quality-of-life in CIDP patients, cell and organ transplantation. Specific Research Priorities include: Graft versus Host Disease (GvHD) following: Hematopoietic Cell Transplant (HCT) Burden of disease, natural course of disease, and understanding the role of cond
Text Inhalt Text aus URL
Log Metriken 1036330
erkannte Namen Grant Provider |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords behring areas | with including | studies diseases | that health | disease learn | products research | clinical your | more patients | application quality | initiated investigator |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
CIDP) including wear-off, dose titration, dose conversion from intravenous immunoglobulins (IVIg) to subcutaneous immunoglobulins (SCIg), loading dose and dosing by body mass index (BMI) or fat percent versus weight, quality-of-life in CIDP patients, cell and organ transplantation. Specific Research Priorities include: Graft versus Host Disease (GvHD) following: Hematopoietic Cell Transplant (HCT) Burden of disease, natural course of disease, and understanding the role of cond
Text Inhalt Text aus URL
Log Metriken 1036330
www.cslbehring.ch
Datum der Indexierung 15.01.2024 02:34:58
erkannte Namen Grant Provider |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords behring areas | with including | studies learn | that diseases | disease research | products health | clinical your | initiated more | application patients | investigator quality |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
CIDP) including wear-off, dose titration, dose conversion from intravenous immunoglobulins (IVIg) to subcutaneous immunoglobulins (SCIg), loading dose and dosing by body mass index (BMI) or fat percent versus weight, quality-of-life in CIDP patients, cell and organ transplantation. Specific Research Priorities include: Graft versus Host Disease (GvHD) following: Hematopoietic Cell Transplant (HCT) Burden of disease, natural course of disease, and understanding the role of cond
Text Inhalt Text aus URL
Log Metriken 1036330
erkannte Namen Grant Provider |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords behring areas | with including | studies learn | that diseases | disease research | products health | clinical your | initiated more | application patients | investigator quality |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
CIDP) including wear-off, dose titration, dose conversion from intravenous immunoglobulins (IVIg) to subcutaneous immunoglobulins (SCIg), loading dose and dosing by body mass index (BMI) or fat percent versus weight, quality-of-life in CIDP patients, cell and organ transplantation. Specific Research Priorities include: Graft versus Host Disease (GvHD) following: Hematopoietic Cell Transplant (HCT) Burden of disease, natural course of disease, and understanding the role of cond
Text Inhalt Text aus URL
Log Metriken 1036330
www.cslbehring.ch
Datum der Indexierung 10.01.2024 05:10:09
erkannte Namen Grant Provider |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords behring areas | with including | studies learn | that diseases | disease research | products health | clinical your | initiated more | application patients | investigator quality |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
CIDP) including wear-off, dose titration, dose conversion from intravenous immunoglobulins (IVIg) to subcutaneous immunoglobulins (SCIg), loading dose and dosing by body mass index (BMI) or fat percent versus weight, quality-of-life in CIDP patients, cell and organ transplantation. Specific Research Priorities include: Graft versus Host Disease (GvHD) following: Hematopoietic Cell Transplant (HCT) Burden of disease, natural course of disease, and understanding the role of cond
Text Inhalt Text aus URL
Log Metriken 1036330
erkannte Namen Grant Provider |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords behring areas | with including | studies learn | that diseases | disease research | products health | clinical your | initiated more | application patients | investigator quality |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
CIDP) including wear-off, dose titration, dose conversion from intravenous immunoglobulins (IVIg) to subcutaneous immunoglobulins (SCIg), loading dose and dosing by body mass index (BMI) or fat percent versus weight, quality-of-life in CIDP patients, cell and organ transplantation. Specific Research Priorities include: Graft versus Host Disease (GvHD) following: Hematopoietic Cell Transplant (HCT) Burden of disease, natural course of disease, and understanding the role of cond
Text Inhalt Text aus URL
Log Metriken 1036330
www.cslbehring.ch
Datum der Indexierung 21.01.2024 21:25:55
erkannte Namen Grant Provider |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords behring areas | with including | studies learn | that diseases | disease research | products health | clinical your | initiated more | application patients | investigator quality |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
CIDP) including wear-off, dose titration, dose conversion from intravenous immunoglobulins (IVIg) to subcutaneous immunoglobulins (SCIg), loading dose and dosing by body mass index (BMI) or fat percent versus weight, quality-of-life in CIDP patients, cell and organ transplantation. Specific Research Priorities include: Graft versus Host Disease (GvHD) following: Hematopoietic Cell Transplant (HCT) Burden of disease, natural course of disease, and understanding the role of cond
Text Inhalt Text aus URL
Log Metriken 1036330
erkannte Namen Grant Provider |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords behring areas | with including | studies learn | that diseases | disease research | products health | clinical your | initiated more | application patients | investigator quality |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
CIDP) including wear-off, dose titration, dose conversion from intravenous immunoglobulins (IVIg) to subcutaneous immunoglobulins (SCIg), loading dose and dosing by body mass index (BMI) or fat percent versus weight, quality-of-life in CIDP patients, cell and organ transplantation. Specific Research Priorities include: Graft versus Host Disease (GvHD) following: Hematopoietic Cell Transplant (HCT) Burden of disease, natural course of disease, and understanding the role of cond
Text Inhalt Text aus URL
Log Metriken 1036330
www.cslbehring.ch
Datum der Indexierung 08.01.2024 08:26:05
erkannte Namen Grant Provider |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords studies news | with through | behring support | that factor | disease high | initiated erfahren | application mehr | investigator quality | clinical including | products research |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
CIDP) including wear-off, dose titration, dose conversion from intravenous immunoglobulins (IVIg) to subcutaneous immunoglobulins (SCIg), loading dose and dosing by body mass index (BMI) or fat percent versus weight, quality-of-life in CIDP patients, cell and organ transplantation. Specific Research Priorities include: Graft versus Host Disease (GvHD) following: Hematopoietic Cell Transplant (HCT) Burden of disease, natural course of disease, and understanding the role of cond
Text Inhalt Text aus URL
Log Metriken 1036337
erkannte Namen Grant Provider |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords studies news | with through | behring support | that factor | disease high | initiated erfahren | application mehr | investigator quality | clinical including | products research |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
CIDP) including wear-off, dose titration, dose conversion from intravenous immunoglobulins (IVIg) to subcutaneous immunoglobulins (SCIg), loading dose and dosing by body mass index (BMI) or fat percent versus weight, quality-of-life in CIDP patients, cell and organ transplantation. Specific Research Priorities include: Graft versus Host Disease (GvHD) following: Hematopoietic Cell Transplant (HCT) Burden of disease, natural course of disease, and understanding the role of cond
Text Inhalt Text aus URL
Log Metriken 1036337
www.cslbehring.ch
Datum der Indexierung 21.01.2024 21:20:17
erkannte Namen Grant Provider |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords studies news | with patients | behring mehr | that through | disease support | products factor | initiated high | clinical research | investigator quality | application including |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
CIDP) including wear-off, dose titration, dose conversion from intravenous immunoglobulins (IVIg) to subcutaneous immunoglobulins (SCIg), loading dose and dosing by body mass index (BMI) or fat percent versus weight, quality-of-life in CIDP patients, cell and organ transplantation. Specific Research Priorities include: Graft versus Host Disease (GvHD) following: Hematopoietic Cell Transplant (HCT) Burden of disease, natural course of disease, and understanding the role of cond
Text Inhalt Text aus URL
Log Metriken 1036325
erkannte Namen Grant Provider |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords studies news | with patients | behring mehr | that through | disease support | products factor | initiated high | clinical research | investigator quality | application including |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
CIDP) including wear-off, dose titration, dose conversion from intravenous immunoglobulins (IVIg) to subcutaneous immunoglobulins (SCIg), loading dose and dosing by body mass index (BMI) or fat percent versus weight, quality-of-life in CIDP patients, cell and organ transplantation. Specific Research Priorities include: Graft versus Host Disease (GvHD) following: Hematopoietic Cell Transplant (HCT) Burden of disease, natural course of disease, and understanding the role of cond
Text Inhalt Text aus URL
Log Metriken 1036325